Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases discusses how nanotechnology aids in overcoming the existing traditional approaches in combating diseases. The book explores the emerging trends of using nanoparticles for nanotherapeutics and nanotheranostics and their role in the efficient diagnosis and treatment of infectious microbial diseases. Sections covers nanotherapeutic impregnated medical devices, nanotherapeutics as vaccines, related regulatory requirements, the application of nanotherapeutics and nanotheranostics in diagnosing and treating specific infectious diseases, including bacterial infections, viral infections, fungal infestations, parasitic infestations, and other infectious conditions.
With chapter contributions from experts in the fields, this book offers a comprehensive reference for researchers, scientists, and industry professionals working on infectious diseases and the application of nanoparticles to effectively diagnose, treat, and manage them.
1. Section I: Introduction - p. xv 2. Chapter 1. The pursuit of nanotherapeutics: Drug delivery, recent advances, and future perspectives - p. 3 3. Chapter 2. An overview of nanotherapeutics and nanodiagnostics - p. 19 4. Chapter 3. Nanotherapeutics-impregnated medical devices and their regulatory aspects - p. 41 5. Chapter 4. Nanotherapeutics as vaccines and their regulatory aspects - p. 63 6. Section II: Applications of nanotherapeutics and nanotheranostics in bacterial infections - p. 77 7. Chapter 5. Nanotherapeutics in pulmonary infections - p. 81 8. Chapter 6. Nanotherapeutics in gastric infections - p. 115 9. Chapter 7. Nanotherapeutics for skin and soft tissue infections - p. 135 10. Chapter 8. Nanotherapeutics in wound infection including diabetic foot ulcer - p. 157 11. Chapter 9. Nanotherapeutics in ocular infections - p. 187 12. Chapter 10. Nanotherapeutics in the management of bone infections - p. 205 13. Chapter 11. Nanotherapeutics in tuberculosis: Pulmonary and extrapulmonary applications - p. 239 14. Chapter 12. Nanotherapeutics against bacterial biofilms - p. 269 15. Chapter 13. Nanotherapeutics against drug-resistant pathogens - p. 293 16. Chapter 14. Applications of nanotherapeutics and nanotheranostics in the management of various bacterial infections - p. 307 17. Section III: Applications of nanotherapeutics and nanotheranostics in viral infections - p. 337 18. Chapter 15. Nanotherapeutics in human immunodeficiency viruses infections - p. 341 19. Chapter 16. Nanotherapeutics in COVID-19 and associated pulmonary infections - p. 371 20. Chapter 17. Nanotherapeutics in Japanese encephalitis virus infections management - p. 401 21. Chapter 18. Nanotherapeutics in miscellaneous viral infections - p. 425 22. Section IV: Applications of nanotherapeutics and nanotheranostics in fungal infestations - p. 451 23. Nanotherapeutics in Candidiasis - p. 455 24. Chapter 20. Nanotherapeutics and nanotheranostics in miscellaneous fungal infections - p. 473 25. Section V: Applications of nanotherapeutics and nanotheranostics in parasitic infestations - p. 491 26. Chapter 21. Nanotherapeutics in malaria - p. 495 27. Chapter 22. Nanotherapeutics in leishmaniasis - p. 523 28. Section VI: Applications of nanotherapeutics and nanotheranostics in miscellaneous infestations - p. 550 29. Chapter 23. Nanotherapeutics in cancer-associated infections - p. 553 30. Chapter 24. Nanotherapeutics in septicemia - p. 583 31. Nanotherapeutics and nanotheranostics in Trueperella pyogenes infections - p. 607 32. Chapter 26. Nanotherapeutics in metabolic diseases–Associated infections - p. 617 33. Chapter 27. Pharmacokinetics of nanoparticles for infectious diseases - p. 649 34. Index - p. 665
Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases discusses how nanotechnology aids in overcoming the existing traditional approaches in combating diseases. The book explores the emerging trends of using nanoparticles for nanotherapeutics and nanotheranostics and their role in the efficient diagnosis and treatment of infectious microbial diseases. Sections covers nanotherapeutic impregnated medical devices, nanotherapeutics as vaccines, related regulatory requirements, the application of nanotherapeutics and nanotheranostics in diagnosing and treating specific infectious diseases, including bacterial infections, viral infections, fungal infestations, parasitic infestations, and other infectious conditions.
With chapter contributions from experts in the fields, this book offers a comprehensive reference for researchers, scientists, and industry professionals working on infectious diseases and the application of nanoparticles to effectively diagnose, treat, and manage them.
1. Section I: Introduction - p. xv 2. Chapter 1. The pursuit of nanotherapeutics: Drug delivery, recent advances, and future perspectives - p. 3 3. Chapter 2. An overview of nanotherapeutics and nanodiagnostics - p. 19 4. Chapter 3. Nanotherapeutics-impregnated medical devices and their regulatory aspects - p. 41 5. Chapter 4. Nanotherapeutics as vaccines and their regulatory aspects - p. 63 6. Section II: Applications of nanotherapeutics and nanotheranostics in bacterial infections - p. 77 7. Chapter 5. Nanotherapeutics in pulmonary infections - p. 81 8. Chapter 6. Nanotherapeutics in gastric infections - p. 115 9. Chapter 7. Nanotherapeutics for skin and soft tissue infections - p. 135 10. Chapter 8. Nanotherapeutics in wound infection including diabetic foot ulcer - p. 157 11. Chapter 9. Nanotherapeutics in ocular infections - p. 187 12. Chapter 10. Nanotherapeutics in the management of bone infections - p. 205 13. Chapter 11. Nanotherapeutics in tuberculosis: Pulmonary and extrapulmonary applications - p. 239 14. Chapter 12. Nanotherapeutics against bacterial biofilms - p. 269 15. Chapter 13. Nanotherapeutics against drug-resistant pathogens - p. 293 16. Chapter 14. Applications of nanotherapeutics and nanotheranostics in the management of various bacterial infections - p. 307 17. Section III: Applications of nanotherapeutics and nanotheranostics in viral infections - p. 337 18. Chapter 15. Nanotherapeutics in human immunodeficiency viruses infections - p. 341 19. Chapter 16. Nanotherapeutics in COVID-19 and associated pulmonary infections - p. 371 20. Chapter 17. Nanotherapeutics in Japanese encephalitis virus infections management - p. 401 21. Chapter 18. Nanotherapeutics in miscellaneous viral infections - p. 425 22. Section IV: Applications of nanotherapeutics and nanotheranostics in fungal infestations - p. 451 23. Nanotherapeutics in Candidiasis - p. 455 24. Chapter 20. Nanotherapeutics and nanotheranostics in miscellaneous fungal infections - p. 473 25. Section V: Applications of nanotherapeutics and nanotheranostics in parasitic infestations - p. 491 26. Chapter 21. Nanotherapeutics in malaria - p. 495 27. Chapter 22. Nanotherapeutics in leishmaniasis - p. 523 28. Section VI: Applications of nanotherapeutics and nanotheranostics in miscellaneous infestations - p. 550 29. Chapter 23. Nanotherapeutics in cancer-associated infections - p. 553 30. Chapter 24. Nanotherapeutics in septicemia - p. 583 31. Nanotherapeutics and nanotheranostics in Trueperella pyogenes infections - p. 607 32. Chapter 26. Nanotherapeutics in metabolic diseases–Associated infections - p. 617 33. Chapter 27. Pharmacokinetics of nanoparticles for infectious diseases - p. 649 34. Index - p. 665
